Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about NeuClone aggregated by PharmaCompass.com.

    Client Virtual Booth

    NEUCLONE

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    NeuClone
    Australia Flag
    Country
    Country
    Australia
    Address
    Address
    Australian Technology Park, National Innovation Centre 4 Cornwallis Street, Eveleigh Sydney NSW 2015
    Telephone
    Telephone
    +612 9209 4020
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://neuclone.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/neuclone-pty-ltd
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    NeuClone Announces Positive Results from Phase I Study of Stelara® (ustekinumab)
    NeuClone Announces Positive Results from Phase I Study of Stelara® (ustekinumab)

    https://www.businesswire.com/news/home/20201020005445/en

    BUSINESSWIRE
    20 Oct 2020
    Share Share
    NeuClone Discloses Two Biosimilars Referencing Opdivo® and Keytruda®
    NeuClone Discloses Two Biosimilars Referencing Opdivo® and Keytruda®

    https://www.businesswire.com/news/home/20200901005308/en/NeuClone-Discloses-Biosimilars-Referencing-Opdivo%C2%AE-Keytruda%C2%AE#:~:text=NeuClone%20Discloses%20Two%20Biosimilars%20Referencing%20Opdivo%C2%AE%20and%20Keytruda,-%C2%AE&text=These%20biosimilars%20reference%20two%20antibody,patients%20across%20multiple%20oncology%20settings.

    BUSINESSWIRE
    01 Sep 2020
    Share Share
    NeuClone Announces Completion of Subject Visits in Stelara® (ustekinumab
    NeuClone Announces Completion of Subject Visits in Stelara® (ustekinumab

    https://www.businesswire.com/news/home/20200408005128/en

    BUSINESSWIRE
    08 Apr 2020
    Share Share
    NeuClone Announces Completion of Subject Visits in Stelara® (ustekinumab)
    NeuClone Announces Completion of Subject Visits in Stelara® (ustekinumab)

    https://www.businesswire.com/news/home/20200408005128/en/NeuClone-Announces-Completion-Subject-Visits-Stelara%C2%AE-ustekinumab/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==

    BUSINESSWIRE
    08 Apr 2020
    Share Share
    ​NeuClone Completes Dosing in Phase I Clinical Trial of Stelara
    ​NeuClone Completes Dosing in Phase I Clinical Trial of Stelara

    https://www.businesswire.com/news/home/20191218005072/en/%E2%80%8BNeuClone-Completes-Dosing-Phase-Clinical-Trial-Stelara%C2%AE

    BUSINESS WIRE
    18 Dec 2019
    Share Share
    NeuClone Announces Positive Results from Phase I Study of Herceptin
    NeuClone Announces Positive Results from Phase I Study of Herceptin

    https://www.businesswire.com/news/home/20191205005324/en

    BUSINESSWIRE
    05 Dec 2019
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search